News on CCR5 from BioPortfolio.com http://www.BioPortfolio.com Consolidated CCR5 news from BioPortfolio.com Tue, 09 Feb 2010 22:18:05 GMT en CCR5 area variants linked to HDL cholesterol and triglyceride level variationhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037210&HITNO=0&MSIZE=32&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=CCR5&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037210&THISHREF=http://c.moreover.com/click/here.pl%3fz2536960085%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037210&HITNO=0&MSIZE=32&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=CCR5&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037210&THISHREF=http://c.moreover.com/click/here.pl%3fz2536960085%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMedWire News: Avexa Announces Positive HIV Therapy Trialshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4020385&HITNO=1&MSIZE=32&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=CCR5&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4020385&THISHREF=http://c.moreover.com/click/here.pl%3fz2526737935%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4020385&HITNO=1&MSIZE=32&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=CCR5&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4020385&THISHREF=http://c.moreover.com/click/here.pl%3fz2526737935%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmaceutical Technology: Merck & Co: potential remains for HIV drug despite trial disappointmenthttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3995317&HITNO=2&MSIZE=32&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=CCR5&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3995317&THISHREF=http://c.moreover.com/click/here.pl%3fz2515593010%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3995317&HITNO=2&MSIZE=32&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=CCR5&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3995317&THISHREF=http://c.moreover.com/click/here.pl%3fz2515593010%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPipelineReview: Research from Pfizer Inc. in the area of HIV/AIDS publishedhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4001757&HITNO=3&MSIZE=32&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=CCR5&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4001757&THISHREF=http://c.moreover.com/click/here.pl%3fz2518555311%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4001757&HITNO=3&MSIZE=32&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=CCR5&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4001757&THISHREF=http://c.moreover.com/click/here.pl%3fz2518555311%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNewsRX: HIV/AIDS: Research from Pfizer Inc. in the area of HIV/AIDS publishedhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3995653&HITNO=4&MSIZE=32&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=CCR5&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3995653&THISHREF=http://c.moreover.com/click/here.pl%3fz2515807833%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3995653&HITNO=4&MSIZE=32&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=CCR5&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3995653&THISHREF=http://c.moreover.com/click/here.pl%3fz2515807833%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNewsRX: Vicriviroc, a CCR5 Inhibitor, Hits Major Roadblock in Developmenthttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3986504&HITNO=5&MSIZE=32&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=CCR5&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3986504&THISHREF=http://c.moreover.com/click/here.pl%3fz2509213279%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3986504&HITNO=5&MSIZE=32&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=CCR5&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3986504&THISHREF=http://c.moreover.com/click/here.pl%3fz2509213279%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comThe Body: Early Immune System Changes and Level of HIV in Cells Predict Later Disease Progressionhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3980358&HITNO=6&MSIZE=32&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=CCR5&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3980358&THISHREF=http://c.moreover.com/click/here.pl%3fz2506337193%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3980358&HITNO=6&MSIZE=32&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=CCR5&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3980358&THISHREF=http://c.moreover.com/click/here.pl%3fz2506337193%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comHIV and Hepatitis.com: High prevalence of natural polymorphisms in Gag (CA-SP1) associated with reduced response to Bevirimat, an HIV-1 maturation inhibitor and HIV protease inhibitorshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3967985&HITNO=7&MSIZE=32&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=CCR5&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3967985&THISHREF=http://c.moreover.com/click/here.pl%3fz2500074492%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3967985&HITNO=7&MSIZE=32&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=CCR5&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3967985&THISHREF=http://c.moreover.com/click/here.pl%3fz2500074492%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNational AIDS Treatment Advocacy Project: Rational Design of Micro-RNA-like Bifunctional siRNAs Targeting HIV and the HIV Coreceptor CCR5http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3967087&HITNO=8&MSIZE=32&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=CCR5&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3967087&THISHREF=http://c.moreover.com/click/here.pl%3fz2499433201%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3967087&HITNO=8&MSIZE=32&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=CCR5&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3967087&THISHREF=http://c.moreover.com/click/here.pl%3fz2499433201%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMolecular Therapy: Experimental therapy kept patient's HIV level low patienthttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3960918&HITNO=9&MSIZE=32&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=CCR5&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3960918&THISHREF=http://c.moreover.com/click/here.pl%3fz2496502217%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3960918&HITNO=9&MSIZE=32&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=CCR5&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3960918&THISHREF=http://c.moreover.com/click/here.pl%3fz2496502217%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comChina Post: Epitope Switching as a Novel Escape Mechanism of HIV to CCR5 Monoclonal Antibodieshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3952397&HITNO=10&MSIZE=32&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=CCR5&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3952397&THISHREF=http://c.moreover.com/click/here.pl%3fz2490775524%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3952397&HITNO=10&MSIZE=32&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=CCR5&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3952397&THISHREF=http://c.moreover.com/click/here.pl%3fz2490775524%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comAAC: Merck & Co: potential remains for HIV drug despite trial disappointmenthttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3952762&HITNO=11&MSIZE=32&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=CCR5&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3952762&THISHREF=http://c.moreover.com/click/here.pl%3fz2490974448%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3952762&HITNO=11&MSIZE=32&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=CCR5&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3952762&THISHREF=http://c.moreover.com/click/here.pl%3fz2490974448%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmacy Choice: Mercks HIV Drug Fails to Meet Phase III Endpointhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3953128&HITNO=12&MSIZE=32&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=CCR5&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3953128&THISHREF=http://c.moreover.com/click/here.pl%3fz2491254217%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3953128&HITNO=12&MSIZE=32&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=CCR5&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3953128&THISHREF=http://c.moreover.com/click/here.pl%3fz2491254217%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comContract Pharma: Ex Vivo Comparison of Microbicide Efficacies for Preventing HIV-1 Genomic Integration in Intraepithelial Vaginhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3952395&HITNO=13&MSIZE=32&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=CCR5&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3952395&THISHREF=http://c.moreover.com/click/here.pl%3fz2490775332%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3952395&HITNO=13&MSIZE=32&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=CCR5&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3952395&THISHREF=http://c.moreover.com/click/here.pl%3fz2490775332%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comAAC: Merck Will Not Seek Approval of CCR5 Antagonist Vicriviroc for Treatment-experienced HIV Patientshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3946437&HITNO=14&MSIZE=32&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=CCR5&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3946437&THISHREF=http://c.moreover.com/click/here.pl%3fz2487551579%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3946437&HITNO=14&MSIZE=32&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=CCR5&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3946437&THISHREF=http://c.moreover.com/click/here.pl%3fz2487551579%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comHIV and Hepatitis.com: